Amunix Pharmaceuticals

Synthekine

This company develops engineered cytokine therapeutics and protein engineering platforms for patients with cancer and autoimmune or inflammatory diseases.

Bright Peak Therapeutics

This biotechnology company develops engineered cytokine immunotherapies and immunoconjugates to treat patients with cancer and autoimmune diseases.

Cold Start Therapeutics

This company develops multimeric fusion proteins using machine learning to target cancer cells and engage immune cells for patients with oncological diseases.

Jounce Therapeutics

This clinical-stage biopharmaceutical company develops immunotherapy treatments for cancer patients by using a platform that enables the immune system to attack tumours.

ATB Therapeutics

The company develops engineered antibody therapies for patients with cancer and autoimmune diseases using a proprietary bioengineering platform.

CytomX

This biopharmaceutical company develops conditionally activated antibody therapeutics for oncology patients and healthcare providers.

EdiTy Therapeutics

This company develops immune cell delivery platforms to transport therapeutic proteins into diseased cells for patients with cancer and genetic disorders.

Vittoria Biotherapeutics

This company develops engineered T-cell therapies for patients with cancer and immunological disorders using its proprietary cell manufacturing platform.